Delaware
|
|
000-55809
|
|
82-1873116
|
(State or other jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer
|
of incorporation)
|
|
|
Identification No.)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
• |
Capsules
|
• |
Topical Products
|
• |
Oral Drops, films, and troches
|
• |
Suppositories
|
• |
Hair and scalp Conditioners
|
• |
Lotions and Creams
|
• |
Sprays and Powders
|
· |
Very large and predictable streams of revenue through the ongoing sale of enhanced bioavailability CBD products and consumables.
|
· |
Insulated from deleterious changes in the economy as people will continue to require CBD infused on a regular basis.
|
· |
Demand currently outpaces supply tremendously.
|
· |
In house laboratory operations that ensure that the highest quality.
|
· |
Proprietary processes and procedures for enhancing the bioavailability of CBD.
|
· |
Operates as a distributor or manufacturer of consumable goods
|
· |
Is a brand firm that is looking to enter the CBD products market
|
· |
Generates revenues in excess of $10 million per year
|
· |
Will spend $100,000 to $1.5 million per year via purchase orders.
|
|
Common Shares
|
Percentage
|
||||||
|
Owned
|
Of Class(1)
|
||||||
|
||||||||
Mark Palumbo (2)(3)
President, Secretary, Treasurer and Director
|
4,800,000
|
66
|
%
|
(1) |
Based on 7,200,000 common stock shares outstanding.
|
(2) |
Consists of 3,000,000 shares initially owned in the Company as a result of the change in control and 1,800,000 shares received in exchange for membership interests in Xceptor, LLC owned by him pursuant to the Acquisition.
|
(3) |
Mr. Palumbo’s address is 412 North Main Street, Buffalo, Wyoming 82834.
|
2.1*
|
|
|
3.1
|
|
|
3.2
|
|
|
3.3
|
|
|
99.1*
|
|
* |
Filed herewith
|
Balance Sheets as of March 31, 2018 (Unaudited) and December 31, 2017
|
F-2
|
|
|
||
Statement of Operations for the Three Months Ended March 31, 2018 (Unaudited)
|
F-3
|
|
|
||
Statement of Cash Flows for the Three Months Ended March 31, 2018 (Unaudited)
|
F-4
|
|
|
||
Notes to Financial Statements (Unaudited)
|
F-5
|
Xceptor LLC
Balance Sheets
|
||||||||
March 31,
2018
|
December 31,
2017 |
|||||||
(unaudited)
|
||||||||
ASSETS
|
||||||||
Current assets:
|
||||||||
Cash
|
$
|
485
|
$
|
380
|
||||
Total assets
|
$
|
485
|
$
|
380
|
||||
LIABILITIES AND MEMBERS’ EQUITY (DEFICIT)
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
450
|
-
|
||||||
Loan payable
|
1,000
|
1,000
|
||||||
Total current liabilities
|
$
|
1,450
|
$
|
1,000
|
||||
Commitments and contingencies
|
-
|
-
|
||||||
Members’ Equity (Deficit):
|
||||||||
Contributed capital
|
4,471
|
4,471
|
||||||
Accumulated deficit
|
(5,436
|
)
|
(5,091
|
)
|
||||
Total members’ deficit
|
(965
|
)
|
(620
|
)
|
||||
Total liabilities and members’ equity
|
$
|
485
|
$
|
380
|
Xceptor LLC
Statement of Operations
(unaudited)
|
||||
For the Three
Months Ended March 31, 2018 |
||||
Revenue
|
$
|
153
|
||
Operating expenses:
|
||||
General and administrative
|
498
|
|||
Total operating expenses
|
498
|
|||
Net
loss
|
$
|
(345
|
)
|
Xceptor LLC
Statement of Cash Flows
(unaudited)
|
||||
For the Three Months Ended
March 31, 2018 |
||||
Cash flows from operating activities:
|
||||
Net loss
|
$
|
(345
|
)
|
|
Adjustments to reconcile net loss to net cash provided by
operating activities:
|
||||
Changes in Operating Assets and Liabilities:
|
||||
Accounts payable
|
450
|
|||
Net cash
provided by
operating activities
|
105
|
|||
Cash flows from Investing activities:
|
-
|
|||
|
||||
Cash flows from Financing activities:
|
-
|
|||
Net increase in cash
|
105
|
|||
Cash, beginning of period
|
380
|
|||
Cash, end of period
|
$
|
485
|
||
Supplemental Disclosure of Cash Flow Information:
|
||||
Cash paid for interest
|
$
|
-
|
||
Cash paid for taxes
|
$
|
-
|
Report of Independent Registered Public Accounting Firm
|
F-8
|
|||
Balance Sheet as of December 31, 2017
|
F-9
|
|||
|
||||
Statement of Operations from inception on September 12, 2017 through the year ended December 31, 2017
|
F-10
|
|||
|
||||
Statement of Members’ Equity from inception on September 12, 2017 through the year ended December 31, 2017
|
F-11
|
|||
Statement of Cash Flows from inception on September 12, 2017 through the year ended December 31, 2017
|
F-12
|
|||
|
||||
Notes to Financial Statements
|
F-13
|
Xceptor LLC
Balance Sheet
|
||||
December 31, 2017
|
||||
ASSETS
|
||||
Current assets:
|
||||
Cash
|
$
|
380
|
||
Total assets
|
$
|
380
|
||
LIABILITIES AND MEMBERS’
EQUITY (DEFICIT)
|
||||
Current liabilities:
|
||||
Loan payable
|
1,000
|
|||
Total current liabilities
|
$
|
1,000
|
||
Commitments and contingencies
|
-
|
|||
Members’ Equity (Deficit):
|
||||
Contributed capital
|
4,471
|
|||
Accumulated deficit
|
(5,091
|
)
|
||
Total members’ deficit
|
(620
|
)
|
||
Total liabilities and members’ equity
|
$
|
380
|
Xceptor LLC
Statement of Operations
|
||||
From inception on
September 12, 2017 through December 31, 2017 |
||||
Revenue
|
$
|
232
|
||
Operating expenses:
|
||||
Product testing
|
2,255
|
|||
General and administrative
|
3,068
|
|||
Total operating expenses
|
5,323
|
|||
Net
loss
|
$
|
(5,091
|
)
|
Xceptor LLC
Statement of Members’ Equity
December 31, 2017
|
||||||||||||
Contributed
|
Accumulated
|
|||||||||||
Capital
|
Deficit
|
Total
|
||||||||||
September 12, 2017
, (date of inception)
|
$
|
-
|
$
|
-
|
$
|
-
|
||||||
Contributed capital
|
4,471
|
-
|
4,471
|
|||||||||
Net loss for the year ended December 31,
2017 |
-
|
(5,091
|
)
|
(5,091
|
)
|
|||||||
Balance, December 31, 2017
|
$
|
4,471
|
$
|
(5,091
|
)
|
$
|
(620
|
)
|
Xceptor LLC
Statement of Cash Flows
|
||||
From inception on September
12, 2017 through December 31, 2017 |
||||
Cash flows from operating activities:
|
||||
Net loss
|
$
|
(5,091
|
)
|
|
Net cash used in operating activities
|
(5,091
|
)
|
||
Cash flows from Financing activities:
|
||||
Proceeds from loan
|
1,000
|
|||
Contributed capital
|
4,471
|
|||
Net cash provided by financing activities
|
5,471
|
|||
Net increase in cash
|
380
|
|||
Cash, beginning of period
|
-
|
|||
Cash, end of year
|
$
|
380
|
||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW
INFORMATION: |
||||
Cash paid for interest
|
$
|
-
|
||
Cash paid for taxes
|
$
|
-
|
|
CANNASSIST INTERNATIONAL CORP.
|
|
|
Date: July 13, 2018
|
/s/
Mark Palumbo
By: Mark Palumbo
President
|
(i) |
all tangible personal property, including all machinery, equipment, tools, spare parts, furniture, fixtures, vehicles, accessories, office materials, packaging and shipping materials, office equipment, computers, telephones, facsimile machines, file cabinets, artwork and drawings and other tangible personal property, together with any express or implied warranty by the manufacturers or sellers of such tangible personal property or any component part thereof (to the extent transferable);
|
(ii) |
all inventory and supplies, including finished goods, work in process and raw materials used or held for use by XCEPTOR;
|
|
CANNASSIST INTERNATIONAL CORP.
|
|
|
|
|
|
By
|
|
|
|
Mark Palumbo, President
|
|
|
|
|
XCEPTOR LLC
|
|
|
|
|
|
By
|
|
|
|
Mark Palumbo, Manager
|
Signature
|
|
Xceptor LLC Membership
Interests Held |
|
|
|
|
|
|
|
|
60%
|
|
Mark Palumbo
|
|
|
|
|
|
Printed name
|
|
40%
|
|
Marla Palumbo
|
|
|
|
|
|
Printed name
|
Signature
|
Xceptor LLC Membership
Interests held |
Total Number of CannAssist
International Corp. Common Stock Shares to
be Issued
|
||
By:
|
|
60%
|
|
1,800,000
|
Printed name: Mark Palumbo
|
|
|
|
|
By:
|
|
40%
|
|
1,200,000
|
Printed name: Marla Palumbo
|
CannAssist International Corp
Proforma Balance Sheet
|
||||||||||||||||
March 31, 2018
|
||||||||||||||||
Xceptor, LLC
|
CannAssist
International Corp |
Elimination
|
Proforma
|
|||||||||||||
ASSETS
|
||||||||||||||||
Current assets:
|
||||||||||||||||
Cash
|
$
|
485
|
$
|
-
|
$
|
-
|
$
|
485
|
||||||||
Total assets
|
$
|
485
|
$
|
-
|
$
|
-
|
$
|
485
|
||||||||
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
|
||||||||||||||||
Current liabilities:
|
||||||||||||||||
Accounts payable
|
$
|
450
|
$
|
-
|
$
|
-
|
$
|
450
|
||||||||
Accrued liabilities
|
-
|
1,250
|
-
|
1,250
|
||||||||||||
Loan payable
|
1,000
|
-
|
-
|
1,000
|
||||||||||||
Total current liabilities
|
1,450
|
1,250
|
-
|
2,700
|
||||||||||||
Stockholders' Equity (Deficit):
|
||||||||||||||||
Common Stock par value $0.0001 100,000,000 shares
authorized, 20,000,000 shares issued and outstanding |
-
|
2,000
|
-
|
2,000
|
||||||||||||
Additional paid in capital
|
4,471
|
1,712
|
(4,962
|
)
|
1,221
|
|||||||||||
Accumulated deficit
|
(5,436
|
)
|
(4,962
|
)
|
4,962
|
(5,436
|
)
|
|||||||||
Total stockholders' deficit
|
(965
|
)
|
(1,250
|
)
|
-
|
(2,215
|
)
|
|||||||||
Total liabilities and stockholders' equity
|
$
|
485
|
$
|
-
|
$
|
-
|
$
|
485
|
CannAssist International Corp
Proforma Statement of Operations
|
||||||||||||||||
For the Three Months Ended March 31, 2018
|
||||||||||||||||
Xceptor, LLC
|
CannAssist
International Corp |
Elimination
|
Proforma
|
|||||||||||||
Revenue
|
$
|
153
|
$
|
-
|
$
|
-
|
$
|
153
|
||||||||
Operating expenses:
|
||||||||||||||||
General and administrative
|
498
|
650
|
-
|
1,148
|
||||||||||||
Total operating expenses
|
498
|
650
|
-
|
1,148
|
||||||||||||
Net loss
from operations
|
$
|
(345
|
)
|
$
|
(650
|
)
|
$
|
-
|
$
|
(995
|
)
|
|||||
Net Loss
|
$
|
(345
|
)
|
$
|
(650
|
)
|
$
|
-
|
$
|
(995
|
)
|
CannAssist International Corp
Proforma Balance Sheet
|
||||||||||||||||
December 31, 2017
|
||||||||||||||||
Xceptor, LLC
|
CannAssist
International Corp |
Elimination
|
Proforma
|
|||||||||||||
ASSETS
|
||||||||||||||||
Current assets:
|
||||||||||||||||
Cash
|
$
|
380
|
$
|
-
|
$
|
-
|
$
|
380
|
||||||||
Total assets
|
$
|
380
|
$
|
-
|
$
|
-
|
$
|
380
|
||||||||
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
|
||||||||||||||||
Current liabilities:
|
||||||||||||||||
Loan payable
|
$
|
1,000
|
$
|
-
|
$
|
-
|
$
|
1,000
|
||||||||
Accrued liabilities
|
-
|
2,000
|
-
|
2,000
|
||||||||||||
Total current liabilities
|
1,000
|
2,000
|
-
|
3,000
|
||||||||||||
Stockholders' Equity (Deficit):
|
||||||||||||||||
Common Stock par value $0.0001
100,000,000 shares authorized, 20,000,000 shares issued and outstanding |
-
|
2,000
|
-
|
2,000
|
||||||||||||
Additional paid in capital
|
4,471
|
312
|
(4,312
|
)
|
471
|
|||||||||||
Accumulated deficit
|
(5,091
|
)
|
(4,312
|
)
|
4,312
|
(5,091
|
)
|
|||||||||
Total stockholders' deficit
|
(620
|
)
|
(2,000
|
)
|
-
|
(2,620
|
)
|
|||||||||
Total liabilities and stockholders' equity
|
$
|
380
|
$
|
-
|
$
|
-
|
$
|
380
|
CannAssist International Corp
Proforma Statement of Operations
|
||||||||||||||||
For the year ended December 31, 2017
|
||||||||||||||||
Xceptor, LLC
|
CannAssist
International Corp |
Elimination
|
Proforma
|
|||||||||||||
Revenue
|
$
|
232
|
$
|
-
|
$
|
-
|
$
|
232
|
||||||||
Operating expenses:
|
||||||||||||||||
Product testing
|
2,255
|
-
|
-
|
2,255
|
||||||||||||
General and administrative
|
3,068
|
4,312
|
-
|
7,380
|
||||||||||||
Total operating expenses
|
5,323
|
4,312
|
-
|
9,635
|
||||||||||||
Net loss
from operations
|
(5,091
|
)
|
(4,312
|
)
|
-
|
(9,403
|
)
|
|||||||||
Net Loss
|
$
|
(5,091
|
)
|
$
|
(4,312
|
)
|
$
|
-
|
$
|
(9,403
|
)
|